noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Healthcare

Results

Ionis Pharmaceuticals Inc.

11/02/2021 | Press release | Distributed by Public on 11/02/2021 05:13

Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Sharing and Personal Tools

Please select the service you want to use:

Smartlinks | Ionis Pharmaceuticals Inc. | News | Health | Science | Research | Local News | Business and Economy | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Top Company News | Issue of Shares and Capital Increase | Business Announcement | Products and Services | Corporate Litigation and Regulation | Public Share Offering | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Düsseldorf | Börse München | Börse Stuttgart | Bolsa Mexicana de Valores (BMV) | BX Swiss | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Global Select Market | BZX Exchange | BYX Exchange | EDGA Exchange | EDGX Exchange | NYSE National | Nasdaq BX | Nasdaq PSX | NYSE Chicago | Bolsa Institucional de Valores (BIVA)

Back